Tralokinumab, CAS [[1044515-88-9]]

Produktübersicht

• Artikelname: Tralokinumab, CAS [[1044515-88-9]]
• Artikelnummer: TGM-T76704
• Hersteller Artikelnummer: T76704
• Alternativnummer: TGM-T76704-1MG,TGM-T76704-5MG,TGM-T76704-10MG,TGM-T76704-25MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: CAT-354 , LP 0162

Produktbeschreibung

Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumabs potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD).

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1044515-88-9]
• Target-Kategorie: Caspase|||Cadherin|||Interleukin|||Apoptosis|||IL Receptor